The treatment of medical plants: Opportunity and feasability of domestic [Serbia&Montenegro] industry
2003
Dugalic, S.L. (Visa skola za sportske trenere, Beograd (Serbia and Montenegro))
This paper presents some results of research and practice regarding the manufacture of phytotherapy products, which can be useful for managers working on problems of technological restructuring as follows: 1) The feasability study for this production shows that the profit margin is between 10 and 25%; 2) The know-how for the production of phytotherapy products ranges from 12.5 to 25.5% of the total investment in new technology, which can be a great advantage in the development of original (domestic) technology and its export to other countries (example Hemafarm); 3) The development of these products and realized profit improve research for new indication and initiate the production of other equipment (machines for packing, transport etc.). Furthermore, some extremely passive regions could be incorporated into such production. The production of phytopharmacy products has a social target supplying the market with cheap medical compounds obtained from plants without any undesired side effects in the treatment.
Afficher plus [+] Moins [-]Mots clés AGROVOC
Informations bibliographiques
Cette notice bibliographique a été fournie par Unassigned data from Yugoslavia
Découvrez la collection de ce fournisseur de données dans AGRIS
